Novelix Pharmaceuticals Limited (BOM:536565)
India flag India · Delayed Price · Currency is INR
69.00
-1.05 (-1.50%)
At close: Nov 16, 2026

Novelix Pharmaceuticals Revenue

Novelix Pharmaceuticals had revenue of 447.31M INR in the quarter ending September 30, 2026, with 22.92% growth. This brings the company's total for the last twelve months to 1.55B, up 82.85% year-over-year. In the fiscal year ending March 31, 2026, Novelix Pharmaceuticals had annual revenue of 1.32B with 330.60% growth. That makes Novelix Pharmaceuticals the 34,949th largest company in the world by revenue and 2,846th in India.

Revenue (ttm)
1.55B
Revenue Growth
+82.85%
P/S Ratio
1.28
Revenue / Employee
48.51M
Employees
32
Market Cap
1.96B

Revenue Chart

Revenue by Segment

  • Pharma Business 295.09M 96.0%
  • Trading in Shares 12.09M 3.9%
  • Finance 159.58K 0.1%
Fiscal year ended Mar 31, 2025 See the full Novelix Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 20261.32B1.02B330.60%
Mar 31, 2025307.33M262.02M578.26%
Mar 31, 202445.31M26.11M135.96%
Mar 31, 202319.20M-69.92M-78.45%
Mar 31, 202289.13M-6.72M-7.01%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.